Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Paget Disease, Extramammary × Fluorescein × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Paget Disease, Extramammary 1

Interventions

Specimen Handling 2 Nivolumab 2 talimogene laherparepvec 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Fluorescein 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06873815 2026-01-12

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡